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Abstract
Background: T cell migration is essential for immune responses and inflammation. Activation of the T-cell receptor (TCR)
triggers a migration stop signal to facilitate interaction with antigen-presenting cells and cell retention at inflammatory
sites, but the mechanisms responsible for this effect are not known.
Methodology/Principal Findings: Migrating T cells are polarized with a lamellipodium at the front and uropod at the rear.
Here we show that transient TCR activation induces prolonged inhibition of T-cell migration. TCR pre-activation leads to
cells with multiple lamellipodia and lacking a uropod even after removal of the TCR signal. A similar phenotype is induced
by expression of constitutively active Rac1, and TCR signaling activates Rac1. TCR signaling acts via Rac to reduce
phosphorylation of ezrin/radixin/moesin proteins, which are required for uropod formation, and to increase stathmin
phosphorylation, which regulates microtubule stability. T cell polarity and migration is partially restored by inhibiting Rac or
by expressing constitutively active moesin.
Conclusions/Significance: We propose that transient TCR signaling induces sustained inhibition of T cell migration via Rac1,
increased stathmin phosphorylation and reduced ERM phosphorylation which act together to inhibit T-cell migratory polarity.
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Introduction
T cells play a pivotal role in the immune response against
infections, in transplant rejection, and autoimmune diseases. T cell
migration is essential for their recruitment to sites of inflammation,
but only T cells specific for relevant antigens are retained at these
sites [1], implying that their migration is selectively inhibited by
interaction with antigen (Ag) presenting cells (APCs). This
activation involves the recognition of a specific Ag presented by
major histocompatibility complex molecules to the TCR, together
with co-stimulatory signals that cooperate to activate the T cell
fully. T cell activation initiates a cascade of signals leading to cell
proliferation and cytokine production. TCR engagement also
rapidly induces a stop signal to inhibit T cell migration, allowing
stable conjugate formation between T cells and APCs [2–4].
However, although signalling by the TCR has been extensively
studied, little is known of the mechanisms that stop migration [4].
In order to migrate, T cells undergo a dramatic re-organization
of membrane domains and the cytoskeleton to acquire a polarized
morphology with an actin-rich lamellipodium at the front and a
uropod at the rear [4–6]. The formation of these structures is
controlled by members of the Rho GTPase family of proteins,
including RhoA, Rac1/2 and Cdc42 [6,7]. These GTPases cycle
between an active GTP-bound form and inactive GDP-bound
form, and regulate a variety of cytoskeletal molecules [8,9]. In
migrating cells, Rac and Cdc42 proteins are believed to stimulate
actin polymerization at the leading edge to induce extension of
lamellipodia and filopodia respectively while RhoA regulates
actomyosin contractility and retraction of the rear of the cell [10].
Lymphocytes express the closely related isoforms Rac1 and
Rac2. T cells derived from Rac2-deficient mice have defects in
TCR-induced signaling and proliferation [11] as well as reduced
chemotaxis to chemokines [12]. T cells deficient for Rac1 and
Rac2 appear to be more strongly defective in TCR-stimulated
signaling than cells lacking only Rac1 or Rac2, suggesting some
functional redundancy between the two isoforms [13]. So far the
consequence of Rac1 knock-out on T cell chemotaxis has not been
addressed, but expression of dominant negative Rac1 inhibits T
cell migration [14]. RhoA is also implicated in T cell polarization
[14], uropod protrusion [15] and uropod retraction [16]. Rho
GTPases affect cell polarity in part by regulating the localization
and activity of the ezrin/radixin/moesin (ERM) family of proteins
[7]. ERM proteins bind to a variety of membrane receptors and to
phosphoinositides through their N-terminal FERM domain, and
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between the actin cytoskeleton and membrane receptors. ERM
proteins are important for uropod formation in T cells, and several
ERM-binding receptors, including CD44 and ICAM-3, co-
localize with ERM proteins in the uropod [7,15]. Their activity
is stimulated by C-terminal threonine phosphorylation (T558 in
moesin) [17], which unfolds the proteins from an autoinhibited
conformation, and is mediated by a number of different kinases
depending on cell type and cell cycle status [7,18].
Here we report that activation of the TCR inhibits T cell
polarization and migration even after the TCR stimulus is
removed, and that this involves increased Rac activity, which
induces decreased ERM phosphorylation, increased stathmin
phosphorylation and loss of a stable uropod together with
formation of multiple lamellipodial protrusions. Expression of
constitutively active Rac1 similarly inhibits cell polarization, and
this can be rescued by expression of phosphomimetic moesin-
T558D. Increased Rac activity following TCR engagement
therefore leads to loss of a stable migratory polarity by co-
ordinately increasing frontness signals (lamellipodia) and decreas-
ing backness signals (uropod).
Results
TCR activation inhibits T cell migration after removal of
TCR stimulus
It has previously been reported that engagement of the TCR
inhibits T-cell migration. Consistent with this, when T cells
migrating on ICAM-1-coated surfaces encountered anti-CD3
antibody (OKT3)-coated beads we observed rapid inhibition of
cell polarization and migration upon TCR engagement. In
contrast, control anti-CD28 antibody-coated beads did not affect
T-cell migration (Figure 1A–C, Movies S1, S2).
To determine whether the effect of TCR stimulation on
migration is maintained after removal of the TCR stimulus, TCR
signaling was activated by plating T cells on anti-CD3 antibodies
for 45 min, a length of time similar to the formation of a mature
immunological synapse [19]. Cells were subsequently removed
from the plates and added to transwell filters coated with ICAM-1
or fibronectin, which are ligands for the T-cell integrins LFA-1
(aLß2) and/or VLA-4 (a4ß1) respectively (Figure 2A). We found
that TCR stimulation for 45 min was sufficient to inhibit T-cell
migration on ICAM-1 in the absence of ongoing TCR
Figure 1. TCR activation by anti-CD3-coated beads impairs T cell polarization and migration. Beads coated with anti-CD3 or anti-CD28
(control) antibody were added to T cells migrating on ICAM-1 and images acquired every 30 sec. (A) Cells displaying a non-polarized (grey bars) or
polarized (black bars) morphology upon T cell-bead contact were counted. Mean of 3 independent experiments +/2 S.E.M. (B) Cells were tracked
upon bead-contact. The graph shows the mean migration speed +/2 S.E.M. of 3 independent experiments, n=7–10 cells/experiment. *p,0.05,
Student’s t-test. (C) Consecutive frames of time-lapse microscopy movies are shown. Numbers on each frame indicate seconds after the start of the
movie. Arrows indicate a cell interacting with an antibody-coated bead in each condition. Scale bars, 40 mm (CD28) or 20 mm (CD3).
doi:10.1371/journal.pone.0012393.g001
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PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e12393Figure 2. TCR activation inhibits T cell migration and impairs polarity. T cells were plated on the indicated antibodies for 45 min then
removed from plates prior to each experiment. (A) Antibody-pre-stimulated T cells were added to transwell filters coated with fibronectin (FN; grey
bars), ICAM-1 (black bars) or uncoated, without substrate (w/o subs; white bars). (B) Quantification of T cell TEM through TNF-a-activated endothelial
cell monolayers on transwells. The number of migrated cells in the lower chamber was determined after 3 h. (C) TEM across endothelial cells on glass
coverslips was analysed by time-lapse microscopy. The number of T cells that transmigrated within each 10-min interval from 0 to 60 min was
determined; no tr.: cells that did not undergo transendothelial migration. Results (A–C) are the mean of 3 independent experiments +/2 S.E.M.
*p,0.05 compared to IgG, Student’s t-test. (D,E) Antibody-pre-treated T cells were plated on ICAM-1 and imaged by time-lapse microscopy. (D)
Migration speed of cells expressed as the mean of the average speed in five different experiments +/2 S.E.M.; 50 cells per condition; * p,0.05
compared to IgG, Student’s t-test. Scale bar, 10 mm. (E) Representative images of a control IgG-pre-stimulated and CD3-pre-stimulated T cell on ICAM-
1. L: lamellipodium/leading edge, U: uropod, P: protrusion. Numbers on each frame indicate seconds after the start of the movie. Scale bar =10 mm.
TCR, Rac and T-Cell Migration
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incubated with different antibodies to the TCR (Figure S1A). The
T cells used in our assays are activated by stimulation with
phytohemagglutinin (PHA) and IL-2, and resemble memory T
cells [20]. Co-incubation of cells with anti-CD28 and anti-CD3
antibodies did not alter the inhibitory effect of CD3 on migration
(Figure 2A), consistent with the observation that memory T cells
and human T cells activated in vitro are not dependent on CD28
co-stimulation for TCR-induced responses [21,22]. Although it
has been reported that T cell migration is increased upon CD28
cross-linking [20], under our experimental conditions CD28
activation with plate-bound antibody did not affect subsequent
migration.
TCR engagement transiently activates LFA-1 and increases the
strength of adhesion to ICAM-1, but this is reversed by 30 min
[23]. Consistent with this, under our conditions (45 min of CD3
engagement), subsequent adhesion of T cells to ICAM-1 following
removal from anti-CD3 antibodies was not altered (Figure S1B),
indicating that the effect of CD3 activation on T cell migration
was not due to changes in cell adhesion. T cell transendothelial
migration (TEM) requires adhesion to endothelial ICAM-1. As
well as reducing migration of CD3-activated cells on ICAM-1-
coated surfaces, pre-treatment of T cells with anti-CD3 antibody
efficiently inhibited TEM and delayed the time at which TEM
occurred (Figure 2B and C). Co-incubation with anti-CD3 and
anti-CD28 antibodies again did not significantly alter migration
compared to CD3 alone. CD3 activation therefore inhibits T cell
migration without affecting cell adhesion.
TCR activation inhibits T cell polarization on ICAM-1
To identify the stage at which TCR engagement affects T cell
migration, we monitored the migration of CD3 antibody pre-
treated cells on ICAM-1 by time-lapse microscopy. Most control T
cells had a migratory phenotype, characterized by a clear
polarized morphology (Figure 2E, F, Movie S3), with a single
lamella containing an F-actin-rich lamellipodium and highly
dynamic membrane ruffles, and a uropod frequently protruding
out of the plane of migration. Migrating T cells sometimes
extended multiple lamellae but one quickly became dominant and
formed the leading edge. By contrast, following CD3 stimulation,
the majority of cells were unpolarized with multiple actively
ruffling protrusions enriched in F-actin and no well-defined
uropod (Figure 2E, F, Movie S4). These protrusions were relatively
stable compared to the occasional transient multiple lamellae
observed in control cells, but eventually collapsed into the body of
the cell as new protrusions formed in other regions. (Figure S1C,
Movie S4). Consistent with the absence of migratory polarity, CD3
pre-treatment also reduced cell migration speed on ICAM-1 and
the total distance moved (Figure 2D, Figure S1D).
We then analysed whether the CD3-induced phenotype
correlated with changes in the cytoskeleton. Control T cells
migrating on ICAM-1 had an F-actin-rich lamellipodium, whereas
microtubules were concentrated in the uropod and the microtu-
bule-organizing centre (MTOC) was behind the nucleus, as
previously observed [5]. In contrast, CD3-pre-activated cells had
no preferential actin filament accumulation in one part of the cell,
lacked a well-defined uropod and the MTOC was generally
positioned centrally (Figure 2F). The loss of polarity was confirmed
by staining for several membrane proteins that are normally
localized in the uropod of polarized cells, including CD44 and
ICAM-3 (Figure S1E) [6]. These markers displayed a homoge-
neous distribution at the cell surface in cells pre-treated with anti-
CD3 antibodies.
Effect of TCR activation on Rho GTPase activity and
localization
Since Rho GTPases areknown to play a pivotal role in regulating
actin and microtubule dynamics, the effect of TCR signalling on
RhoA, Rac1 and Cdc42 was explored. CD3 stimulated Rac1
activation in T cells, consistent with previous observations in the
Jurkat T cell line [24,25], and decreased RhoA activity, whereas no
change in Cdc42 activity was observed (Figure 3A).
A balance between Rac and RhoA activities has been proposed
to be necessary for the process of neutrophil polarization, with Rac
activation promoting the leading edge ‘‘frontness’’ and locally
inhibiting RhoA, and RhoA activity at the rear of the cells
determining the ‘‘backness’’ [26]. The localization of both total
and active forms of Rac and RhoA was altered in CD3 pre-
stimulated cells (Figure 3B, C). In control cells, Rac1 localized in
lamellipodia and membrane ruffles, around the nucleus and in the
uropod, whereas in CD3-pre-activated cells it had a more
homogeneous distribution (Figure 3B). The localization of active
Rac in cells was determined by incubating fixed cells with purified
GST-PAK-PBD (binds to Rac-GTP). Control staining of cells
expressing constitutively active Rac1, Cdc42 (Figure S2C) or
dominant negative Rac1 (data not shown) indicated that GST-
PAK-PBD recognized the active form of Rac1 in cells but not
Cdc42. Active Rac localized to the membrane at the leading edge
(Figure 3C), as well as in the uropod, where it was predominantly
in vesicular structures around the MTOC and not on the plasma
membrane. This localization of active Rac is similar to results in
neutrophils, where it is found in lamellipodia and the uropod [27].
In anti-CD3 pre-treated cells active Rac was enriched in many of
the multiple protrusions (Figure 3C), consistent with a role in
promoting lamellipodium extension. Both total RhoA and active
Rho (note that the GST-Rtk-RBD probe does not differentiate
between RhoA, RhoB and RhoC) normally localized predomi-
nantly to the uropod with some localization at the front in
lamellipodia, but was found in all protrusions in CD3-pre-
activated cells (Figure 3B, C). Active Rho was also found close
to but did not co-localize with the MTOC in CD3-pre-treated
cells.
TCR activation decreases phosphorylation of ERM
proteins and alters their localization
The uropod is believed to be important for T cell migration,
allowing cells to migrate through constricted spaces and also
participating in the recruitment of other cells [28]. C-terminal
phosphorylation and activation of ERM proteins is necessary for
posterior localization of ERM-binding receptors such as ICAM-3
and CD44 [29], and cooperates with the Rho/ROCK pathway in
stimulating uropod projection [15]. On the other hand, TCR
engagement induces dephosphorylation of ERM proteins via Rac
in T cells, which is proposed to enhance T cell interaction with
APCs [30]. Since anti-CD3-pre-treated cells lacked uropods when
plated on ICAM-1, we investigated the localization of phosphor-
ylated ERM proteins. In control cells, phosphorylated ERM
(F) Antibody-treated cells were plated on ICAM-1 for 30 min, then fixed and stained for F-actin and tubulin. Morphologies were classified into three
groups based on F-actin distribution and MTOC localization (left panels; Scale bar, 20 mm). Mean of % of cells displaying each morphology in 5
independent experiments +/2 S.E.M. (right panel, 100 cells per condition in each experiment).
doi:10.1371/journal.pone.0012393.g002
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were localized primarily in the uropod as expected, whereas in
anti-CD3-pre-treated cells they localized to multiple patches on
the plasma membrane (Figure 4A, B). We then analyzed the
phosphorylation status of ERM proteins following CD3 activation.
ERM phosphorylation was decreased by CD3 engagement
(Figure 4C), but this was reduced following detachment of cells
from anti-CD3 antibody (Figure 4D, t=0). However, CD3 pre-
Figure 3. Regulation of Rho GTPase activity and localization by TCR activation. (A) T cells were starved for 5 h and incubated in anti-CD3 or
control IgG antibody-coated wells. After 45 min cells were lysed and RhoA, Rac1 and Cdc42 activity assayed in pull-down experiments. A
representative experiment out of at least 3 for each Rho GTPase is shown. Graphs show active Rho GTPase (GTP) levels:total levels as mean of 5
experiments (RhoA and Rac1) or 3 experiments (Cdc42) +/2 S.E.M. relative to IgG pre-treated cells. *p,0.05, Students t-test. (B,C) Localization of total
Rac1 and RhoA (B) and active Rac and Rho GTPases (C) in cells plated on ICAM-1. To detect active Rac and Rho, cells were incubated with purified
GST-PAK-PBD (GST-PBD) and GST-Rhotekin-RBD (GST-RBD) respectively followed by anti-GST antibodies. Cells were also incubated with fluorophore-
conjugated phalloidin to localize F-actin and anti-tubulin antibodies as indicated. DIC: differential interference contrast image. Scale bars, 20 mm.
doi:10.1371/journal.pone.0012393.g003
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lation induced by adhesion to ICAM-1 (Figure 4D). Since ERM
phosphorylation is required for uropod formation, this reduction
in ERM phosphorylation on ICAM-1 could be responsible for the
loss of uropods in anti-CD3-pre-treated cells. These results
indicate that transient TCR engagement induces a prolonged
inhibition of polarization of uropod proteins and formation of a
uropod.
Figure 4. TCR activation promotes ERM dephosphorylation and inhibits uropod localization of pERMs. (A–D) T cells were plated on
anti-CD3 antibody or control IgG for 45 min. (A, B) Antibody-pre-treated cells were plated on ICAM-1. After 30 min cells were fixed with TCA and the
localization of pERM and actin (A, B), ICAM-3 (A) and CD44 (B) assessed by immunofluorescence. Representative confocal images are shown. DIC:
differential interference contrast image. Scale bars, 20 mm. (C) Cells were lysed and the levels of phosphorylated ERM proteins (pERM) determined
by western blotting. A representative blot and the mean values of 3 independent experiments +/2 S.E.M. are shown. *p,0.05, Students t-test.
(D) Antibody-pre-treated cells were plated on ICAM-l or kept in suspension (t=0), lysed at the indicated time-points and the levels of pERM
determined by western blotting. A representative blot and the mean values of 4 independent experiments +/2 S.E.M. compared to IgG-pre-treated
cells at t=0 are shown. *p,0.05, Students t-test compared to IgG pre-treated cells at the same time point.
doi:10.1371/journal.pone.0012393.g004
TCR, Rac and T-Cell Migration
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changes MT distribution
As well as regulating the actin cytoskeleton and pERM, Rac1 has
been proposed to stabilize microtubules in epithelial cells by PAK-
induced phosphorylation and inactivation of stathmin, a microtu-
bule-destabilizing protein [31]. Since microtubules can regulate T-
cell polarity and migration [32] we analyzed the phosphorylation
status of stathmin. We found that treatment of cells for 45 min with
anti-CD3 antibody or transfection with constitutively active GFP-
Rac1-L61 strongly increased stathmin phosphorylation (Figure 5A,
Figure 5. TCR activation increases stathmin phosphorylation and alters microtubule organization. T cells were plated on anti-CD3
antibody or control IgG for 45 min. (A) Cells were lysed and the levels of phospho-stathmin (pStathmin) and total stathmin assessed by western
blotting. The graph shows relative levels of phospho-stathmin (normalized to total stathmin) of 3 independent experiments +/2 S.E.M. in arbitrary
units. (B) Antibody pre-treated T cells were collected, plated on ICAM-1 (IC-1) and lysed at the indicated time points. The levels of phospho-stathmin
and total stathmin were assessed by western blotting. Representative blots are shown; the graph shows mean levels of phospho-stathmin
(normalized to total stathmin) of 3 independent experiments +/2 S.E.M. relative to IgG-treated cells at t=0. (C) Antibody pre-treated cells expressing
EB3-GFP were plated on ICAM-1-coated coverslips. Images were collected every 5 sec. Images shown correspond to five consecutive frames, from 130
sec after the start of the movie. Greyscale images (256 greyscale) were converted to indexed color (scale on right) to improve the visualization of
small differences in intensity value. Arrows indicate individual microtubule tips moving towards the leading edge. Tracking images (right panels)
show the movement of EB3-GFP in the 5 frames (see Methods for detail). Scale bars, 10 mm.
doi:10.1371/journal.pone.0012393.g005
TCR, Rac and T-Cell Migration
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were subsequently plated on ICAM-1 in the absence of CD3
antibodies, they retained increased stathmin phosphorylation above
control cells for at least 10 min (Figure 5B). This suggests that
microtubule dynamics are altered by TCR engagement, and that
this effect is maintained after TCR engagement is stopped.
To monitor microtubule dynamics in living cells, T cells were
transfected with EB3-GFP, a microtubule tip-binding protein
previously used to study microtubule dynamics [34]. EB3-GFP
accumulated predominantly at microtubule tips in the uropod in
migrating cells and was also detected moving towards the leading
edge, along the migration axis (Figure 5C, upper panels and Movie
S5). In anti-CD3 pre-treated cells, EB3-GFP moved from the cell
centre outwards to the cell periphery without any preferential
directionality (Figure 5C, lower panels and Movie S6). Microtu-
bule organization is therefore altered by TCR stimulation.
Rac contributes to TCR-induced inhibition of T cell
migration
We then explored whether the higher Rac activity induced
upon TCR stimulation was responsible for its effects on T cell
morphology and migration. T cells expressing constitutively active
Rac1, GFP-Rac1-L61, were similar in morphology to CD3-
activated cells: they had multiple lamellae, lacked a distinguishable
uropod, did not polarize on ICAM-1 and had impaired migration
(Figure 6A, D, Movie S7). To reduce Rac activity, T cells were
incubated with anti-CD3 antibody in the presence of the Rac
inhibitor NSC23766 [35,36]. NSC23766 (1 mM) partially rescued
the CD3-induced inhibition of T cell migration through ICAM-1-
coated transwells (Figure 6B). This concentration inhibited CD3-
induced Rac1 activation but had little effect on RhoA activity
(Figure S2B). Higher doses of NSC23766 strongly reduced basal
Rac1 activity as well as RhoA activity, and inhibited T cell
migration (data not shown), most likely because some Rac and
RhoA activity is needed for migration [37]. It is therefore likely
that TCR engagement activates Rac1 to a higher level than that
required for migration, which then disrupts the balance between
Rac1 and RhoA so that stable migratory polarity is lost.
T cells transfected with Rac1-L61 had decreased levels of
pERM (Figure 6C), in agreement with the observation that
dominant-negative Rac1 inhibits TCR-induced ERM dephos-
phorylation [30]. In addition, in Rac1-L61-expressing cells,
pERM were uniformly distributed on the plasma membrane and
no longer localized to a discrete uropod (Figure 6D), similar to
pERM localization in CD3-activated cells (Figure 4A, B).
Moreover, treatment of cells with NSC23766 increased pERM
levels in CD3-activated cells (Figure 6E). The reduction in pERM
following TCR engagement therefore involves Rac.
To determine whether changes in ERM phosphorylation are
important for TCR-induced inhibition of T cell polarization and
migration, we investigated the effect of moesin mutants. The
Rac1-L61-induced loss of polarized morphology and ICAM-3
localization to the uropod was rescued by co-expression of an
activated form of moesin, moesin-T558D, which mimics C-
terminal phosphorylation [38]. Moesin-TD-expressing cells had a
clear uropod and polarized migratory phenotype (Figure 7A, B). In
contrast, a non-phosphorylatable mutant (moesin-T558A) had no
effect on ICAM-3 localization or cell polarization (Figure 7A, B).
Moreover, moesin-TD but not moesin-TA partially reversed the
Rac1-L61-induced decrease in T cell motility (Figure 7C). The
ability of activated phospho-mimetic moesin-TD to rescue the
polarity defect of cells expressing activated Rac1 indicates the
importance of the uropod in establishing cell polarity. However, it
was not able to rescue migration speed completely, probably
because it did not revert the Rac1-induced increase in stathmin
phosphorylation (Figure 7D) and hence microtubule dynamics.
Discussion
TCR engagement activates many different signaling pathways
that contribute to the formation of a stable T cell-APC interaction
zone or ‘synapse’ and lead to T-cell activation, including
proliferation and secretion of cytokines [4,39]. TCR engagement
is also known to induce a migration stop signal [4]. Here we have
shown that the effect of TCR engagement in inhibiting migration
is maintained even after removal of the TCR stimulus, and that
cell migration is impaired for up to 2 hours. The signaling
pathways responsible for the TCR stop signal have not previously
been investigated in detail. Our results here indicate that TCR
activation of Rac and subsequent decreased ERM phosphoryla-
tion and increased stathmin phosphorylation leads to prolonged
loss of T-cell migratory polarity and hence inhibits migration
(Figure 8). This would allow T cells to polarize their microtubules
towards APCs and form a stable immunological synapse.
TCR engagement has previously been shown to induce
transient ERM dephosphorylation via Rac, and this has been
proposed to promote conjugate formation between T cells and
APCs by reducing cortical rigidity [30,40]. Our data indicate that
this TCR-activated signaling pathway is also central to loss of
migratory polarity in T cells, both inhibiting uropod formation
and promoting extension of multiple protrusions. In our
experiments with anti-CD3-coated beads, TCR engagement
rapidly inhibits cell polarity and migration, consistent with
previous observations of T cells migrating on ICAM-1-containing
lipid bilayers with and without cognate antigen [3]. Interestingly,
we find that the effect of TCR activation on signaling and
migration does not require continuous stimulation, but is retained
after removal of anti-CD3 antibody. We have observed that the
inhibition of migration lasts up to two hours. This suggests that
CD3 treatment induces stable changes in signaling to Rac,
perhaps by decreasing the activities of proteins that normal turn
off Rac activity, including GAPs or GDIs [9]. It would be
interesting to know whether the TCR complex retains activity over
this time. It is also possible that prolonged TCR signaling leads to
the degradation of proteins that directly or indirectly regulate Rac;
for example, RhoA has been shown to be targeted for degradation
by the Smurf1 ubiquitin ligase [41]. This long-term inhibition of
migration might be important for retaining T cells at a site of
inflammation once they have encountered antigen, even if the
APC subsequently dies, for example as the target of a cytotoxic T
cell [42], or the TCR is endocytosed and downregulated [43].
Stathmin destabilizes microtubules, and phosphorylation of
stathmin reduces its activity [44]. TCR stimulation and Rac1
strongly induce stathmin phosphorylation, which will stabilize
microtubules. Microtubule stabilization has in turn been shown to
activate Rac1 in fibroblasts [45]. We postulate that TCR-induced
stathmin phosphorylation, which is sustained after removal of
CD3 stimulation, could prevent T cell polarization on ICAM-1 by
increasing Rac1 activity. In addition, we have shown that RhoA
acts via ROCK to destabilize microtubules [32], and thus TCR-
induced inhibition of RhoA could also contribute to changes in
microtubule dynamics leading to loss of migratory polarity
(Figure 8).
Rac1 and RhoA have opposing effects on ERM proteins in T
lymphocytes: Rac stimulates ERM dephosphorylation while RhoA
increases their phosphorylation [30,46]. In migrating T cells the
presence of active Rac at the leading edge would explain exclusion
of phosphorylated ERM proteins from this region, while Rac
TCR, Rac and T-Cell Migration
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with the plasma membrane but predominantly localized on
vesicles, and is thus unlikely to affect ERM phosphorylation on
the uropod membrane. On the other hand, RhoA is localized in
the uropod of migrating T cells, and could therefore mediate the
accumulation of phosphorylated ERM proteins in this region.
Lymphocyte-oriented kinase (LOK) has recently been shown to
regulate ERM phosphorylation in T cells and also affect migration
[47], and thus it will be interesting to know if LOK acts in the
uropod. In CD3-stimulated cells, increased Rac activation could
be sufficient to account for the reduced ERM phosphorylation.
Altogether, our data support a model for prolonged TCR-
induced inhibition of cell polarization and migration (Figure 8). A
balance between Rac and RhoA activation is necessary for T cell
migratory polarity,withRaccontributing to leading edgeformation
via actin polymerization, and RhoA together with phosphorylated
ERM proteins to uropod formation. We propose that sustained
Rac activation in CD3-activated cells prevents migratory polarity
Figure 6. Rac activation is required for TCR-induced inhibition of migration and polarity. (A) T cells expressing GFP or GFP-Rac1-L61
(constitutively active) were assayed for migration in ICAM-1-coated transwells. The mean of 3 independent experiments +/2 S.E.M. is shown; *p,0.01
compared to GFP, Student’s t-test. (B) T cells treated with anti-CD3 antibodies or IgG, in the absence (open bars) or presence (grey bars) of the Rac
inhibitor NSC23766, were collected in starving medium, washed and assayed for migration in ICAM-1-coated transwells. The mean of 6 independent
experiments +/2 S.E.M. is shown; *p,0.05 compared to IgG, **p,0.05 compared to IgG+NSC23766, #p,0.005 compared to CD3, Student’s t-test.
(C) T cells expressing GFP or GFP-Rac1-L61 were lysed and the levels of the indicated proteins analyzed by western blotting. Representative blots are
shown; the graphs show mean levels of pERM/ERM and pStathmin/total stathmin for 3 experiments +/2 S.E.M. in GFP-Rac1-L61-transfected cells
relative to GFP-transfected cells *p,0.05, Students t-test. (D) GFP-Rac1-L61 induces dephosphorylation of ERM and phosphorylation of stathmin. T
cells expressing GFP-Rac1-L61 or GFP as control and adhered to ICAM-1 for 1 h were fixed and stained with antibodies to the indicated proteins. Scale
bars, 20 mm. (E) Inhibition of Rac reverts CD3-induced ERM dephosphorylation. NSC23766-treated T cells were incubated with IgG (open bars) or anti-
CD3 (grey bars) for 45 min. Expression of the indicated proteins was analysed by western blotting. A representative blot is shown; the graph shows
mean levels of pERM/ERM for 3 experiments +/2 S.E.M. *p,0.05, Students t-test.
doi:10.1371/journal.pone.0012393.g006
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microtubule stability and inducing loss of the uropod via decreased
ERM phosphorylation. Together, these effects result in the loss
of a polarized migratory morphology and prevent efficient
migration, and could therefore account for T cell retention
upon antigen recognition in sites of inflammation and infection.
Materials and Methods
Cell culture and receptor activation
T lymphocytes were prepared as previously described [48] and
cultured in RPMI-1640 containing 10% human AB serum
(BioWest) and 10 U/ml IL-2 (Roche). Experiments were per-
Figure 7. A phosphomimetic moesin mutant reverts Rac1-L61 inhibition of T cell polarization and motility. (A) Cells transfected with
the indicated plasmids were stained for ICAM-3 and the HA tag on moesin. Moe-TD-HA, moesin-T558D-HA; Moe-TA-HA, moesin-T558A-HA.
Representative images are shown. Scale bar, 10 mm. (B) Frequency of each cell morphology; mean of the % of cells in 3 independent experiments +/2
S.E.M. Only transfected cells were analysed. Polarized: cells with uropod and clustering of ICAM-3 (open bars). Non-polarized: Cells with multiple
protrusions or absence of uropod and homogeneously distributed ICAM-3 (black bars). (C) T cells expressing the indicated proteins were imaged by
time-lapse microscopy on ICAM-1; migration speed of transfected cells pre-treated with the indicated antibodies is the mean of the average speed in
four different experiments +/2 S.E.M.; p,0.05, Student’s t-test compared to GFP (*) or compared to GFP-Rac1-L61 (**). (D) T cells expressing the
indicated proteins were lysed and the phosphorylation of stathmin analyzed by western blotting. A representative blot is shown; the graph shows
mean levels of pStathmin/total stathmin for 3 experiments +/2 S.E.M. *p,0.05, Students t-test.
doi:10.1371/journal.pone.0012393.g007
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vein endothelial cells (HUVECs; BioWhittaker) were cultured as
previously described [48].
For receptor activation T cells were incubated for 5 h in starving
medium (RPMI 1640 containing 1% heat-inactivated FCS). Wells
were coated with monoclonal antibodies against CD3 (OKT3,
1 mg/ml; a gift from Dr. M. Garin, Imperial College London, UK,
or purchased from BioLegend; or for Fig. S1A, MEM57 and
MEM92, a gift from Dr. V Horejsi, Institute of Molecular Genetics,
Prague, Czech Republic), CD28 (5 mg/ml; BD Bioscience) or
control mouse IgG in 50 mM Tris-HCl, pH 9.5 (3 h, 37uC) and
blocked with 2.5% BSA/PBS (1 h). For some experiments OKT3
wasobtainedfromCellswereincubatedinantibody-coatedwellsfor
45 min and collected with starving medium. Alternatively, T cells
were incubated with 6-mm Polybead Microspheres (PolyScience),
which had been coated with anti-CD3 or anti-CD28 antibodies
(16 h, 4uC) and blocked in 1% BSA/PBS.
T cell migration and transendothelial migration
For transwell assays, T cells were incubated in starving medium
for 5 h, incubated with plate-bound antibodies for 45 min then
added to 3-mm pore transwell membranes coated with human
fibronectin (2 mg/ml; Sigma-Aldrich), ICAM-1-Fc (5 mg/ml; R&D
Systems) or uncoated. Where indicated, cells were incubated with
the Rac inhibitor NSC23766 (Calbiochem). For transendothelial
migration (TEM), starved T cells (3610
5 per well) were added to
confluent HUVECs grown on 5-mm pore transwells pre-coated
with fibronectin (10 mg/ml). Migrated cells were counted after 3 h
in a Casy Counter (Scharfe System).
For time-lapse microscopy, T cells were plated on ICAM-1 or on
confluent HUVECs grown on fibronectin-coated coverslips. Images
were collected every 30 sec for 1 h on an Axiovert (Zeiss) or a
TE2000-E Eclipse (Nikon) inverted microscope with a 206objective.
Cells were tracked with Kinetic Imaging software and analysed with
Tempus Meteor software(Andor Technology) and notebooks written
in Mathematica 6.0 (Wolfram Research Institute)[49] or with
MetaMorph 5.01 software (Molecular Devices).
Adhesion assay
Starved T cells were labelled with 29,79,-bis-(2-carboxyethyl)-5-
(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF; Molecular
Probes) in serum-free medium for 20 min, washed with medium
containing 1% BSA and incubated with antibodies. Cells (10
5 per
condition) were added to ICAM-1-coated wells for 1 h. Non-adhered
cells were washed off and adhesion determined by fluorescence
measurement in a Fusion a-FS fluorimeter (PerkinElmer).
Immunofluorescence
Cells were fixed with 4% paraformaldehyde, permeabilized with
0.2% Triton X-100 in PBS, blocked with 1% BSA in PBS, then
stained with antibodies and/or for F-actin using FITC- or TRITC-
conjugated phalloidin (Sigma-Aldrich). For pERM staining, cells
were fixed with 10% TCA for 15 min at 4uC. Actin in TCA-fixed
samples was detected with a goat anti-actin antibody. The following
antibodies were used: a-tubulin, ß-tubulin-FITC (Sigma-Aldrich),
CD44 (BD Bioscience), ICAM-3 (Abcam), RhoA, actin (Santa Cruz
Biotechnology), Rac1, Rac2 (Upstate/Millipore), GFP (Roche),
Cdc42, phospho-ERM, and ERM (Cell Signalling). Fluorophore-
conjugated secondary antibodies were from Jackson ImmunoR-
esearch. Images were acquired with a 40x/1.3 NA objective using a
LSM510 confocal laser-scanning microscope (Zeiss).
Rho GTPase activity assays
The activity of RhoA, Rac1 and Cdc42 was determined by
binding to GST-rhotekin-RBD, GST-PAK-PBD and GST-
WASP-PBD respectively [50,51]. Cells (10
7 per condition) were
harvested in buffer (50 mM Tris HCl pH 7.4, 500 mM NaCl,
10 mM MgCl2, 2 mM EDTA pH 8.0, 10% glycerol, 0.5% b-
mercaptoethanol, 1% Triton X-100, 0.1% SDS, 0.5% sodium
deoxycholate, 1 mM DTT, 0.2 mM sodium orthovanadate,
1 mM PMSF, 1 mM NaF, 1 mg/ml aprotinin and leupeptin); cell
lysates were incubated for 45 min with GST-fusion proteins on
glutathione-sepharose beads. Bound proteins were solubilized in
Laemmli loading buffer and Rho GTPases detected by western
blotting. The relative level of active Rho GTPase was quantified
by densitometric analysis, normalizing to the ‘total Rho GTPase’
control for each sample.
For active Rac and Rho localization by immunofluorescence,
GST-PAK-PBD and GST-Rhotekin-RBD were affinity-purified
from bacterial lysates with glutathione-sepharose beads and eluted
with 10 mM glutathione in 100 mM Tris-HCl pH 8.0 for 10 min
at room temperature. Cells were fixed and permeabilized as
described above. After blocking with 3% BSA in PBS for 20 min,
the cells were incubated with the eluted GST-PAK-PBD or GST-
Rhotekin-RBD (final concentration 2.5 mg/100 ml of blocking
solution) for 1 h, followed by rabbit anti-GST antibody (Sigma-
Aldrich) and secondary goat anti-rabbit antibody.
Western blots
Cell lysates were separated in 4–12% Bis-Tris Gels, transferred
to Immobilon P membranes (Millipore) and blotted with
antibodies to the indicated proteins. The following antibodies
Figure 8. Schematic model for mechanisms leading to TCR-
induced loss of migratory polarity. TCR engagement by antigen
leads to activation of Rac1 (increased Rac1-GTP) and inhibition of RhoA
(decreased RhoA-GTP). Active Rac1 stimulates stathmin phosphoryla-
tion, leading to microtubule stabilization, and reduces ERM phosphor-
ylation, leading to loss of uropod structures. Active RhoA normally
stimulates ERM phosphorylation and reduces microtubule stability, and
these responses are reduced when RhoA activity decreases. Loss of the
uropod together with increased microtubule stability reduces migratory
polarity and hence inhibits migration.
doi:10.1371/journal.pone.0012393.g008
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Biotechnology), anti-Rac1 (clone 23A8, Upstate), anti-Cdc42, anti-
phospho-ERM, anti-ERM and anti-stathmin (Cell Signaling) and
anti-GFP (Roche). Secondary antibodies were from Amersham.
When required membranes were stripped with 8 M guanidinium
hydrochloride (pH 3.0) and re-probed.
Transfection and live cell GFP visualization
Cells were nucleofected with plasmids using the appropriate
Amaxa kit (Amaxa Biosystems) according to the manufacturer’s
protocol with minor modifications. Briefly, cells were incubated in
growing medium without antibiotics for 48 h, then washed and
nucleofected (10
6 cells/100 ml). GFP-Rac1-L61 was a gift from
N. Hotchin (University of Birmingham, UK), GFP-Cdc42-L61
from M. Way (London Research Institute, Cancer Research UK),
HA-tagged Moesin-TD (T558D) and Moesin-TA (T558A) were
from J. De ˆlon (Universite ´ Rene ´ Descartes, Paris, France), and EB3-
GFP was from A. Akhamanova (Erasmus University, Netherlands).
After transfection cells were cultured for 6 h in growth medium
without antibiotics or IL-2. Subsequently cells were incubated in
antibody-coated wells as above in starving medium. For migration
assays cells were plated on ICAM-1-coated coverslips in starving
medium. A series of time-lapse images were collected with a
Hamamatsu Orca-ER C4742-95 camera on a Nikon TE2000-E
Eclipse Inverted microscope equipped with an environmental
chamber, using a 100x/1.4 Plan Apo Ph3 Objective and Andor
IQ software (Andor Technology, Belfast, UK). The images were
processed with MetaMorph 5.01 software (Universal Imaging
Systems, Sunnyvale, CA).
For the visualization of EB3-GFP in static images the 256 greyscale
images were converted to indexed color images. Panels to show the
track were made by subtracting each frame from the previous frame,
producing an image of what had moved between frames. The
differences were added together to show all the items moving in the
sequence and subsequently converted to indexed color scale.
Supporting Information
Figure S1 TCR activation impairs T cell polarization but not
adhesion. T cells were incubated for 45 min with the indicated
antibodies to TCR or control IgG prior to each experiment. (A) T
cells incubated with MEM57 and MEM92 antibodies (MEM;
kindly provided by Dr. V Horejsi, Institute of Molecular Genetics,
Prague, Czech Republic) or control IgG were plated on ICAM-1-
coated transwell filters. Migrated cells were counted in the lower
chamber after 3 h. Results are shown as percentage of migrated
cells, mean of three independent experiments +/2 S.E.M.
*p,0.05 compared to control, Student’s t-test. (B) BCECF-
labelled T cells were plated on ICAM-1-coated wells and adhesion
determined after 1 h. Results are shown as % of cells adhered to
ICAM-1 relative to IgG-pre-treated cells, mean of 3 independent
experiments +/2 S.E.M. (C) T cells were plated on ICAM-1-
coated coverslips. Polarized cells and cells with multiple protru-
sions (see Figure 2) were counted. The mean of % of cells in 5
experiments +/2 S.E.M. is shown (at least 15 cells per
experiment). (D) T cells were plated on ICAM-1-coated coverslips
and an image acquired every 30 sec. The vector plots show the
trajectories of 50 cells from 5 independent experiments with the
origin of each cell plotted at the intersection of the axes. (E) T cells
were plated on ICAM-1-coated coverslips, then fixed and stained
after 1 h with antibodies to the indicated proteins and TRITC-
phalloidin to show actin filaments (actin). Confocal images
representative of each condition are shown. Scale bars, 20 mm.
Found at: doi:10.1371/journal.pone.0012393.s001 (3.35 MB TIF)
Figure S2 Regulation of Rho GTPase activity and localization by
TCR activation. (A) GST-PAK-PBD (GST-PBD) staining in cells
expressing GFP, GFP-Rac1-L61 or GFP-Cdc42-L61: T cells
nucleofected with the indicated plasmids were plated on ICAM-1
and fixed, then incubated with purified GST-PBD followed by anti-
GST antibodies, and co-stained for F-actin. Confocal images were
acquired with identical settings of contrast and gain. The higher
level of staining in cells expressing GFP-Rac1-L61 indicates that
GST-PBD recognizes the active form of Rac1. Scale bars, 20 mm
(Rac1) or 10 mm (Cdc42). (B) T cells treated with IgG or CD3 for
45 min with or without the Rac inhibitor NSC23766 (1 mM) as
indicated were harvested and the activity of Rac1 and RhoA
determined inpull-down experiments. Results froma representative
experiment of 3 independent experiments are shown.
Found at: doi:10.1371/journal.pone.0012393.s002 (1.95 MB TIF)
Movie S1 T cell migrating on ICAM-1 interacting with anti-
CD28-coated beads. 1 frame/30 sec for 15 min.
Found at: doi:10.1371/journal.pone.0012393.s003 (3.98 MB
MOV)
Movie S2 T cell migrating on ICAM-1 interacting with anti-
CD3-coated beads. 1 frame/30 sec for 15 min.
Found at: doi:10.1371/journal.pone.0012393.s004 (1.90 MB
MOV)
Movie S3 IgG-pre-treated T cell migrating on ICAM-1. 1
frame/3 sec for 135 sec.
Found at: doi:10.1371/journal.pone.0012393.s005 (3.13 MB
MOV)
Movie S4 CD3 pre-treated T cell migrating on ICAM-1. 1
frame/3 sec for 180 sec.
Found at: doi:10.1371/journal.pone.0012393.s006 (1.95 MB
MOV)
Movie S5 Microtubule dynamics in a control T cell. Cell
transfected with EB3-GFP migrating on ICAM-1; 1 frame/5 sec
for 150 sec. The left panel shows phase-contrast images, the right
panel shows GFP fluorescence.
Found at: doi:10.1371/journal.pone.0012393.s007 (0.39 MB
MOV)
Movie S6 Microtubule dynamics in a CD3-activated cell. Cell
transfected with EB3-GFP and pre-treated with anti-CD3
antibody migrating on ICAM-1; 1 frame/5 sec for 150 sec. The
left panel shows phase-contrast images, the right panel shows GFP
fluorescence.
Found at: doi:10.1371/journal.pone.0012393.s008 (0.77 MB
MOV)
Movie S7 T cell expressing GFP-Rac1-L61 migrating on
ICAM-1. 1 frame/5 sec for 150 sec. The left panel shows GFP
fluorescence, the right panel shows phase-contrast images.
Found at: doi:10.1371/journal.pone.0012393.s009 (1.01 MB
MOV)
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